Business Segments Avacta Group Plc

Equities

Market Closed - London S.E. Other stock markets 10:05:26 11/03/2026 pm IST			5-day change	1st Jan Change
69.00 ^GBX	+0.73%		+0.73%	+18.97%

24/02	Avacta hails new data supporting proprietary preCision platform	AN
24/02	Avacta Therapeutics Plans FAP-Exd's Clinical Trials After 'Favorable' Experimental Analysis	MT

Breakdown by Business Segment (GBP)

Fiscal Period: December	2020	2021	2022	2023	2024
Biological Products
Therapeutics	16.25L	21.62L	54.81L	20.55L	1L
Gross Profit	10L	14.62L	53.53L	20.4L	1L
EBITDA	-	-	-58.41L	-1.36Cr	-1.73Cr
D&A	7L	10L	12.77L	12.81L	12.49L
Operating Income	-89.61L	-1.42Cr	-1.1Cr	-1.74Cr	-2Cr
Diagnostics	5L	8L	41.72L	2.12Cr	-
Gross Profit	2L	6L	18.9L	92.04L	-
EBITDA	-	-	-51.25L	-11.8L	-
D&A	4L	5L	16.6L	23.79L	-
Operating Income	-66.02L	-1.05Cr	-1.34Cr	-44.3L	-
Total Assets	-	-	-	-	-
EBITDA	-	-	-41.22L	-54.03L	-89.1L
D&A	-	-	18T	11T	3L
Operating Income	-36.68L	-44.43L	-82.14L	-65.04L	-1.26Cr
Life Sciences Tools and Services
Life Sciences	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBITDA	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Veterinary Equipment
Animal Health	14.92L	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Gross Profit	10L	-	-	-	-
EBITDA	-	-	-	-	-
D&A	62T	-	-	-	-
Operating Income	-20.62L	-	-	-	-

Geographical breakdown of sales (GBP)

Fiscal Period: December	2020	2021	2022	2023	2024
South Korea	-	14L	54.81L	20.55L	1L
Rest of World	-	-	-	6L	-
Total Assets	-	-	-	51.5L	-
France	-	-	12.96L	41.2L	-
Total Assets	-	-	22.81L	18.38L	-
Rest of Asia	-	74T	7T	-	-
Rest of Europe	7L	1L	2L	36.88L	-
North America	4L	8L	2L	21T	-
Asia	14.73L	-	-	-	-
Outside The United Kingdom	-	-	-	-	-
United Kingdom	10.76L	5L	25.32L	1.28Cr	-
Total Assets	1.42Cr	1.23Cr	3.48Cr	3.82Cr	-